Toronto, Ontario –
May 29, 2012,
Theralase Technologies Inc. (TSXV:
TLT) announced today that Roger Dumoulin-White, President and CEO will present the
latest corporate information at the BioFinance 2012 conference being held in
Toronto, Ontario from May 29 to 30, 2012.
BioFinance
is a leading life sciences investor conference in Canada which showcases more
than 60 diverse life science companies and the investment opportunities that they
present. BioFinance 2012 also features 17 investor presentations that are aimed
at addressing specific financing and management related issues relevant to life
science industries.
Theralase’s
presentation will take place Wednesday, May 30th at 3:00 pm in Company
Presentation Room 1 at the St. Andrew’s Club and Conference Center. Mr. Roger
Dumoulin-White, President and CEO of Theralase will present on the strategic
direction and recent accomplishments of the company followed by a short Q&A
period and longer one-on-one meeting period.
In
other news, Mr. Dumoulin-White was recently interviewed on the TV show “The
Next Biggest Winner” which is due to air on Ichannel on Tuesday, June 5th
at 7:30pm. The Ichannel has over 1.3
million affluent Canadian subscribers who look to its business programming for investment
opportunities. For a sneak preview, please visit http://youtu.be/y8VT6Rwp_gY
About Theralase
Technologies Inc.:
Theralase
Technologies Inc., founded in 1995, designs, develops, manufactures and markets
patented, superpulsed laser technology utilized in biostimulation and
biodestruction applications. Theralase technology is internationally approved
in the safe and effective treatment of pain, inflammation and for the regeneration
of tissue in neural muscular skeletal conditions in both humans and animals. Theralase
is also researching and developing patented Photo Dynamic Compound (PDC) technology
that is focused at targeting and destroying specific cancers, bacteria and
viruses when light activated by Theralase’s proprietary and patented laser
technologies.
For
further information please visit www.theralase.com,
regulatory filings may be viewed by visiting www.sedar.com.
This press release
contains forward-looking statements which reflect the Company's current
expectations regarding future events. The forward-looking statements involve
risks and uncertainties. Actual results could differ materially from those
projected herein. The Company disclaims any obligation to update these
forward-looking statements.
Neither TSX Venture
Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchanges) accepts responsibility for the adequacy
or accuracy of this release.
For More
Information, please contact:
Roger
Dumoulin - White,
President
& CEO
416-447-8455
ext. 225
Kristina
Hachey
Chief
Financial Officer
416-447-8455
ext. 224
khachey@theralase.com
No comments:
Post a Comment